Skip to main content
. 2024 Apr 10;19:200. doi: 10.1186/s13019-024-02652-8

Table 2.

Comparison of multifocal GG/L nodules and second primary lung cancer

Patient characteristics Multifocal GG/L nodules (n = 139) Second primary lung cancer (n = 63) P value**
Age 0.361
< 60 61 (43.9%) 32 (50.8%)
≥ 60 78 (56.1%) 31 (49.2%)
BMI 0.114
≤ 24.9 87 (62.6%) 32 (50.8%)
> 24.9 52 (37.4%) 31 (49.2%)
Sex 0.002
Male 51 (36.7%) 38 (60.3%)
Female 88 (63.3%) 25 (39.7%)
Smoking history 0.000
Yes 40 (28.8%) 35 (55.6%)
No 99 (71.2%) 28 (44.4%)
Drinking history 0.404
Yes 24 (17.3%) 14 (22.2%)
No 115 (82.7%) 49 (77.8%)
Personal history of neoplasia 0.370
Yes 12 (8.6%) 8 (12.7%)
No 127 (91.4%) 55 (87.3%)
Family history of neoplasia 0.462
Yes 40 (28.8%) 15 (23.8%)
No 99 (71.2%) 48 (76.2%)
Family history of lung cancer 0.346
Yes 25 (18.0%) 8 (12.7%)
No 114 (82.0%) 55 (87.3%)
Past medical history 0.785
Yes 48 (34.5%) 23 (36.5%)
No 91 (65.5%) 40 (63.5%)
Presenting symptoms before the first surgery 0.022
Yes 47 (33.8%) 32 (50.8%)
No 92 (66.2%) 31 (49.2%)
Number of resected tumors, n (%) 0.224
2 104 (74.8%) 56 (88.9%)
3 26 (18.7%) 6 (9.5%)
4 6 (4.3%) 1 (1.6%)
5 2 (1.4%) 0 (0.0%)
6 1 (0.7%) 0 (0.0%)
Times the patient underwent surgery, n (%) 0.043
1 83 (59.7%) 28 (44.4%)
2 56 (40.3%) 35 (55.6%)
Types of multiple cancers (simultaneous/metachronous) 0.000
Simultaneous lung cancers 129 (92.8%) 46 (73.0%)
Metachronous lung cancers 10 (7.2%) 17 (27.0%)
Types of surgery (thoracotomy/VATS) 0.000
VATS 73 (52.5%) 15 (23.8%)
Thoracotomy 52 (37.4%) 32 (50.8%)
Thoracotomy and VATS 14 (10.1%) 16 (25.4%)
Type(s) of resection of multiple lesions 0.023
Lobectomy + sublobar resection 75 (54.0%) 29 (46.0%)
Lobectomy + lobectomy 21 (15.1%) 17 (27.0%)
Sublobar resection + sublobar resection 28 (20.1%) 7 (11.1%)
Lobectomy 14 (10.1%) 6 (9.5%)
Pneumonectomy 1 (0.7%) 4 (6.3%)
Relationship of the locations of multiple lesions 0.213
Ipsilateral tumors 90 (64.7%) 35 (55.6%)
Bilateral tumors 49 (35.3%) 28 (44.4%)
With lung nodules not resected* 0.014
Yes 34 (24.5%) 6 (9.5%)
No 105 (75.5%) 57 (90.5%)
The highest stage tumor 0.000
I 116 (83.5%) 35 (55.6%)
II 7 (5.0%) 12 (19.0%)
III 16 (11.5%) 16 (25.4%)

*With lung nodules not resected: the number of patients with unresected nodules in the lungs. **P values of less than 0.05 were considered statistically significant.